Shortage of Mitomycin-C Kyowa (all strengths)

UKMi with input from the Royal College of Ophthalmology and the National Clinical Director for Cancer at NHS England and Improvement, has drafted clinical advice to support local management of this supply disruption. The memo presents supporting information from clinical trials in addition to broad clinical consensus obtained through this comprehensive engagement to help prioritise stocks and present alternative management strategies for the key indications of anal cancer, bladder cancer, glaucoma surgery and ocular tumours.

CancersEyes and visionMitomycinNewsRenal and urologic disordersShortages and discontinuations

Attachments